- Tools for Investors
- Stock News
- Investing Ideas
- Econ & Policy
- Personal Finance
The FDA has sought an update, not a new trial, regarding data management and verification from a study of the treatment of Eliquis the new drug from Bristol-Myers Squibb (NYSE:BMY) and Pfizer (NYSE:PFE) which helps prevent strokes inpatients suffering from non-valvular atrial fibrillation.
Don’t Miss: Is Chesapeake GUILTY of This DAMNING Charge?
In the never-ending run of scandals at Chesapeake (NYSE:CHK), Reuters has exposed a fresh one, this time involving the suppression of land prices allegedly in collusion with Encana (NYSE:ECA) in many deals in Michigan. Apparently Reuters has reviewed emails that go to show Aubrey McClendon directed the operation and may be evidence of violation of federal and state price-fixing laws .
Shares of Ventrus Biosciences (NASDAQ:VTUS) tanked more than 50 percent after its iferanserin drug for hemorrhoidal disease failed phase 3 trials for the elimination of bleeding, itching and pain. Reportedly, Ventrus has aborted further development of the the drug and will move on to its other compounds.
Don't miss one of the biggest bull markets in history! Covers Gold, Silver, Gold & Silver stocks, and miners.
There's always a bull market in some sector! Find the best opportunities in commodities.